Delivery Order SPE2DB20D1109-SPE2DB25FN42S
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,262.13 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 6, 2025. The contract is not designated under any...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,434.97 and is a Firm Fixed Price (FFP) type contract. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 13.5 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $3,376.73 and is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB24D2215|SPE2DB25FGSUR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,808.62 firm fixed-price delivery order is for the supply of 4,568,062,525 units of the prescription medication XTAMPZA ER 27 MG CAPSULE 100S. The contract has an ultimate completion date of April 29, 2025 and does not utilize any set-aside designations, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.84 firm-fixed-price delivery order is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,394.91, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of April 2, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with any set-aside requirements. AmerisourceBergen Drug Corp is the...
This federal contract award with identification number SPE2DX15D3013|SPE2DX24FH2E8 was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The $1,608.74 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 2, 2024 and does not have a set-aside designation, indicating open...
This is a federal delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for XTAMPZA ER CAPS 36MG, a pharmaceutical product, with a ceiling value of $8,225.07. The contract is a firm fixed price, non-set-aside delivery order with a performance period ending on June 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with a ceiling value of $4,028.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...